Vault-13

Propel Bio Management, LLC

Los Angeles, CA · CIK 1969764 · 13F filing filed 2024-08-12

SEC-registered investment adviser since 2022 · limited liability company

As an employer

$154.2m reported value -10.3% vs Q1 2024
24positions
83.3%in top 10
4 new 4 added 0 reduced 8 sold out vs Q1 2024

This report includes the holdings of 1 other manager that shares the investment decisions:

Shares in two reports are counted once in each security's totals.

Holdings, Q2 2024

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 APPLIED THERAPEUTICS INC COM APLT APLT 6,567,858 $30.7m19.89% 19.89% AddedShares held: Q3 2023 —, Q4 2023 5.4m, Q1 2024 6.1m, Q2 2024 6.6m +456.0k +455,952 7.5%
2 PLAINS GP HLDGS L P LTD PARTNR INT A PAGP PAGP 1,372,360 $25.8m16.75% 16.75% NewShares held: Q3 2023 —, Q4 2023 1.4m, Q1 2024 0, Q2 2024 1.4m
3 TSCAN THERAPEUTICS INC COM TCRX TCRX 2,087,139 $12.2m7.92% 7.92% UnchangedShares held: Q3 2023 —, Q4 2023 2.1m, Q1 2024 2.1m, Q2 2024 2.1m
4 MADRIGAL PHARMACEUTICALS INC COM MDGL MDGL 43,032 $12.1m7.82% 7.82% UnchangedShares held: Q3 2023 —, Q4 2023 30.0k, Q1 2024 43.0k, Q2 2024 43.0k
5 ACHIEVE LIFE SCIENCES INC COM ACHV ACHV 2,453,092 $11.5m7.48% 7.48% UnchangedShares held: Q3 2023 —, Q4 2023 0, Q1 2024 2.5m, Q2 2024 2.5m
6 PHATHOM PHARMACEUTICALS INC COM PHAT PHAT 869,927 $9.0m5.81% 5.81% UnchangedShares held: Q3 2023 —, Q4 2023 443.0k, Q1 2024 869.9k, Q2 2024 869.9k
7 AKERO THERAPEUTICS INC COM AKRO AKRO 327,752 $7.7m4.99% 4.99% UnchangedShares held: Q3 2023 —, Q4 2023 100.1k, Q1 2024 327.8k, Q2 2024 327.8k
8 AVIDITY BIOSCIENCES INC COM RNA RNA 178,500 $7.3m4.73% 4.73% UnchangedShares held: Q3 2023 —, Q4 2023 178.5k, Q1 2024 178.5k, Q2 2024 178.5k
9 ARDELYX INC COM ARDX ARDX 924,583 $6.9m4.44% 4.44% AddedShares held: Q3 2023 —, Q4 2023 594.2k, Q1 2024 594.2k, Q2 2024 924.6k +330.4k +330,409 55.6%
10 ABEONA THERAPEUTICS INC COM NEW ABEO ABEO 1,248,044 $5.3m3.43% 3.43% NewShares held: Q3 2023 —, Q4 2023 0, Q1 2024 0, Q2 2024 1.2m
11 FULCRUM THERAPEUTICS INC COM FULC FULC 750,000 $4.7m3.02% 3.02% UnchangedShares held: Q3 2023 —, Q4 2023 750.0k, Q1 2024 750.0k, Q2 2024 750.0k
12 ATHIRA PHARMA INC COM COM 1,492,792 $4.0m2.57% 2.57% UnchangedShares held: Q3 2023 —, Q4 2023 1.5m, Q1 2024 1.5m, Q2 2024 1.5m
13 TELESAT CORP CL A & CL B SHS TSAT TSAT 365,781 $3.3m2.16% 2.16% AddedShares held: Q3 2023 —, Q4 2023 290.8k, Q1 2024 290.8k, Q2 2024 365.8k +75.0k +75,000 25.8%
14 VERRICA PHARMACEUTICALS INC COM COM 424,937 $3.1m2.01% 2.01% NewShares held: Q3 2023 —, Q4 2023 0, Q1 2024 0, Q2 2024 424.9k
15 KURA ONCOLOGY INC COM KURA KURA 130,000 $2.7m1.74% 1.74% UnchangedShares held: Q3 2023 —, Q4 2023 130.0k, Q1 2024 130.0k, Q2 2024 130.0k
16 EIGER BIOPHARMACEUTICALS INC COM NEW CLDN CLDN 146,381 $1.9m1.20% 1.20% UnchangedShares held: Q3 2023 —, Q4 2023 0, Q1 2024 146.4k, Q2 2024 146.4k
17 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 83,259 $1.7m1.11% 1.11% UnchangedShares held: Q3 2023 —, Q4 2023 0, Q1 2024 83.3k, Q2 2024 83.3k
18 KYMERA THERAPEUTICS INC COM KYMR KYMR 56,359 $1.7m1.09% 1.09% UnchangedShares held: Q3 2023 —, Q4 2023 56.4k, Q1 2024 56.4k, Q2 2024 56.4k
19 KAYNE ANDERSON ENERGY INFRST COM KYN KYN 147,033 $1.5m0.99% 0.99% UnchangedShares held: Q3 2023 —, Q4 2023 147.0k, Q1 2024 147.0k, Q2 2024 147.0k
20 TREVI THERAPEUTICS INC COM TRVI TRVI 260,000 $774.8k0.50% 0.50% UnchangedShares held: Q3 2023 —, Q4 2023 0, Q1 2024 260.0k, Q2 2024 260.0k
21 FIDELITY INV MMTRSY 1 680 COMM COMM 317,014 $317.0k0.21% 0.21% AddedShares held: Q3 2023 —, Q4 2023 4.8m, Q1 2024 211.5k, Q2 2024 317.0k +105.5k +105,473 49.9%
22 CYBIN INC COM COM 850,000 $230.3k0.15% 0.15% UnchangedShares held: Q3 2023 —, Q4 2023 850.0k, Q1 2024 850.0k, Q2 2024 850.0k
23 MAAT PHARMA SACA COMM COMM 1,362 $9.8k0.01% 0.01% NewShares held: Q3 2023 —, Q4 2023 0, Q1 2024 0, Q2 2024 1.4k
24 CHINOOK THERAPEUTICS XXX COM COM 79,357 $9.8k0.01% 0.01% UnchangedShares held: Q3 2023 —, Q4 2023 79.4k, Q1 2024 79.4k, Q2 2024 79.4k

Sold out since Q1 2024

SecurityTickerShares held beforeValue then
SIMPLIFY EXCHANGE TRADED FUN HIGH HIGH 1,492,581 $28.0m1.5m shares
DAY ONE BIOPHARMACEUTICALS I 270,664 $4.5m270.7k shares
ISHARES TR MBB MBB 22,400 $2.1m22.4k shares
MIRUM PHARMACEUTICALS INC MIRM MIRM 70,000 $1.8m70.0k shares
MARINUS PHARMACEUTICALS INC MRNS MRNS 180,100 $1.6m180.1k shares
SUTRO BIOPHARMA INC 195,000 $1.1m195.0k shares
X4 PHARMACEUTICALS INC 535,000 $743.6k535.0k shares
ISHARES TR LQD LQD 4,456 $485.3k4.5k shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
MILESTONE PHARMACEUTICALS IN MIST · 13G · filed 2025-12-23 MIST 9.9%≈ $11.9m new 13G 2025-12-23